Windham Capital Partners
New York · Series A–Series C · 16 people tracked
Investment thesis
The firm leverages a distinctive network spanning pharmaceutical, medical device, and digital health markets alongside leading life sciences venture funds to identify and build disruptive healthcare technology companies. The firm seeks businesses that address significant unmet medical needs, demonstrate the potential to transform healthcare delivery, and generate substantial returns for investors through rigorous due diligence and strategic relationship-building.
Source: firm website, verified Jul 21, 2026.
Team · 16 people
from the firm's websiteCo-founder and CEO of Windham Capital Partners with extensive healthcare enterprise software and medical device experience from roles at I-many, Johnson & Johnson companies, and Coopers & Lybrand. Currently serves as board director at multiple portfolio companies.
Co-founder with extensive experience as senior executive and entrepreneur in billing and payments industry. Founded REMITCO and Financial Telesis (both acquired), and served as chairman and CEO of Transactis. Active as LP and advisor to other investment entities.
Co-founder and chairman of Windham Capital Partners, retired as corporate vice president and general counsel of Johnson & Johnson after 30 years with the company. Serves as chairman of Robert Wood Johnson Foundation board and multiple other healthcare institutions. Law degree from NYU School of Law.
Healthcare investment professional who joined Windham in 2023, previously a partner at Providence Ventures. Has led or co-led investments generating over $1 billion in value, with expertise across surgical, medical devices, and healthcare services sectors. MBA in finance from Xavier University.
Physician and digital health leader, currently Chief Digital Health Officer of Emory Healthcare and former Chief Digital Health Officer at Mass General Brigham. Clinical informatics expert with 15 years hospital medicine practice. Triple board-certified in internal medicine, clinical informatics, and pediatrics. MBA from MIT Sloan with AI specialization.
Former Chief Investment Officer of MIT for 19 years and treasurer emeritus of the institution. Serves as director and treasurer at Beth Israel Deaconess Medical Center and trustee at Robert Wood Johnson Foundation and Boston Children's Hospital. Advanced degrees from MIT and Suffolk University.
Retired managing general partner of HealthCare Ventures, which developed and managed 100+ companies with combined market cap exceeding $60 billion. Prior executive roles included worldwide president of Ortho Diagnostic Systems and vice president at Johnson & Johnson International. Serves on multiple private biotech company boards.
Healthcare executive leading global research and development at UnitedHealth Group. Founder and former CEO of MYnetico/Alliance Health Solutions. Experienced board member, published researcher, and grant recipient in healthcare innovation. MD from Temple University School of Medicine.
Founder and chief solutions officer of Helgerson Solutions Group, a healthcare consultancy focused on value-based care models. Previously served as New York's Medicaid Director overseeing $70 billion program and Wisconsin's Medicaid Director. Recognized as one of nation's longest-tenured Medicaid directors.
Healthcare policy expert with three decades of experience advising federal and state governments, health systems, health plans, and technology companies. Founder of Sachs Policy Group, a consulting firm specializing in healthcare policy strategy for industry leaders.
Operations professional handling administrative and executive support functions at Windham. Previously office manager and executive assistant at Interior Marketing Group. BA from University of Hartford.
Leads marketing and business development at Windham Capital Partners. Co-founder and treasure of Lynn Sage Breast Cancer Foundation and CEO of Chill Anywhere. Prior finance experience at Castle Creek Arbitrage, JP Morgan, Credit Suisse, and CIBC. MBA from Northwestern Kellogg School.
Scientist and technology evaluator at Windham with expertise in stem cells and gene/cell therapy. Professor emeritus at Stony Brook University where he directed medical research laboratory for 30 years and published 60+ peer-reviewed papers. MD and PhD in molecular biology with NIH MERIT award recipient.
Investment professional responsible for sourcing, due diligence, and portfolio company support. Previously regulatory affairs specialist at Arthrex on cardiothoracic business unit founding team, with prior venture capital experience at LifeX accelerator. Advanced degrees in biochemistry and bioengineering.
Executive Vice President and Chief Strategy and Digital Officer at Providence, overseeing system strategy and digital innovation for large integrated delivery network. Architect of Digital Innovation Group that has developed partnerships with 150+ health system digital and innovation teams. Expert in enterprise strategy and organizational stakeholder management.
Data scientist and investor with 14 years in leadership roles, specializing in data science investments across multiple industries. CEO of The Self Research Institute, a non-profit focused on personal informatics. PhD candidate in personal informatics with focus on improving quality of life through data.
What they invest in
from 12 of 76 portfolio companiesHealthtech ×9Biotech ×6Medical Devices ×6Digital Health ×4AI & Machine Learning ×3Enterprise Software ×2SaaS ×2FemTech ×1
HQs:United States×5
Investments · showing 60 of 76
founders shown can be your intro pathBiopharmaceutical company integrating patient biology into drug development for mental health conditions.
NCQA-certified SaaS company automating provider credentialing for healthcare providers and payors.
Andros provides data-driven provider network management solutions for healthcare organizations, offering strategic and execution support across the full network lifecycle. The company's platform, Andros Arc, enables health plans and providers to optimize their networks for improved care outcomes and operational efficiency.
Enterprise SoftwareHealthtechSaaS<UNKNOWN>
Mentorship-driven startup accelerator for health technology entrepreneurs with funding and co-working space.
Develops innovative solutions for osteoarthritis, cartilage damage, and musculoskeletal conditions.
ChromaCode develops a High-Definition PCR (HDPCR) multiplexing platform that enables genomic solutions for oncology and precision medicine, offering faster results and cost-effective workflows through automated interpretation and cloud-based software.
AI & Machine LearningBiotechMedical Devices
High-Definition PCR technology enhancing multiplexing capability while lowering costs for molecular diagnostic testing.
Medical device company developing the HARMONI Modular Intra-Ocular System for vision optimization in cataract surgery.
Medicare Advantage plan offering culturally sensitive healthcare combining Eastern and Western medicine.
Medical technology company reducing radiation exposure during medical procedures.
Proprietary technology and system enabling wine access and pouring without removing the cork.
Medication management telepharmacy services addressing suboptimal medication management.
CVRx develops Barostim, an implantable medical device that uses baroreceptor activation to treat heart failure patients and improve their functional capacity and quality of life.
BiotechHealthtechMedical DevicesAustin, US
Clinical stage company with proprietary active implantable technology for treating hypertension and heart failure.
Proprietary liquid biopsy-based diagnostic technology for early cancer detection.
Detection on the Spot technology for food allergen detection spanning industrial and consumer applications.
Novel hearing solution with direct sound delivery technology providing superior sound quality compared to conventional hearing aids.
Provides functional information about mutations and drug responses to enable precision oncology treatments.
Long-term implant for continuous blood glucose monitoring transmitting data to smartphones and devices.
Sophisticated optics for illumination and enhanced visualization in surgical procedures.
Specialty diabetes pharmaceutical company developing needle-free solutions for severe hypoglycemia rescue.
High-performance electronics designed to be invisible, conformable, and wearable for extending human capabilities.
Human genome sequencing and health data company enabling mass adoption of gene sequencing through a genomic and healthcare data marketplace.
Novel office-based, minimally invasive approach for treating benign prostatic hyperplasia.
Neuspera develops an integrated sacral neuromodulation system for treating urinary urge incontinence, using a smart implanted neurostimulator paired with a wireless external battery. The device is designed for women with overactive bladder symptoms.
HealthtechMedical Devices
Developing injectable neuromodulation devices using licensed mid-field powering technology.
Novel cancer therapy using Tumor Treatment Fields operating on different principles than standard treatment modalities.
Sexual wellness and intimate care company delivering groundbreaking solutions for women.
Novel bronchoscopic device and procedure for treating lung diseases including COPD.
Leader in minimally-invasive interventional pain management for sacroiliac joint dysfunction and chronic lower back pain.
Personalized diagnostics leader with proprietary next-generation sequencing methodology for research and clinical oncology.
Medical device company developing novel solutions in aesthetic medicine.
Revelle Aesthetics develops and commercializes the Avéli device, a precision medical technology for cellulite reduction. The company serves aesthetic practitioners and women seeking non-invasive treatments for skin appearance concerns.
FemTechMedical Devices
Eb Bright(Co-Founder and Chief Administrative Officer)Jonathan Podmore(Co-Founder and Chief Technology Officer)
Specialty pharma services augmenting patient access, activation, and adherence programs with mobile navigation.
Science Exchange provides operational infrastructure for life sciences R&D, connecting organizations, suppliers, and workflows to streamline contracting, compliance, onboarding, and financial coordination across the research ecosystem.
BiotechEnterprise SoftwareHealthtechSaaSSan Francisco, US
Elizabeth Iorns(Founder/President & CEO; Chairman of the Board)inDan Knox(Founder & COO)inMark Layden(CEO & Chairman)
Online marketplace for scientific collaboration enabling researchers to order experiments from world-class laboratories.
Marketplace of patients for clinical trial recruitment.
SubjectWell operates a patient network that links individuals to clinical trials and connects them with healthcare providers and pharmaceutical sponsors. The company serves patients, clinical research organizations, and pharmaceutical companies seeking to recruit and retain participants for medical studies.
BiotechDigital HealthHealthtech
Frequently asked questions
- What stage does Windham Capital Partners invest at?
- Windham Capital Partners invests at the Series A, Series B, Series C stages.
- What sectors does Windham Capital Partners focus on?
- Windham Capital Partners focuses on Digital Health, Healthtech, Medical Devices.
- Where is Windham Capital Partners located?
- Windham Capital Partners is headquartered in New York, US.
Similar investors
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
Breyer Capital is a venture capital firm that invests in high-impact entrepreneurs with a strategic focus on companies leveraging artificial intelligence and machine learning to transform technology sectors globally.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
GV is Alphabet's venture capital arm, established in 2009 as Google Ventures. Operating with long time horizons and over $13 billion in assets under management, the firm invests across technology and life sciences sectors from seed to growth stages, supporting 400 active portfolio companies across North America, Europe, and Israel.
Innovestor is a Finnish investment manager that operates across venture capital, real estate, and energy storage sectors. The firm invests in early-stage technology and life science startups, energy-efficient commercial real estate, and battery storage and solar solutions. Innovestor also provides corporate venturing advisory services.